KWMG
ANGO icon

King Wealth Management Group’s AngioDynamics ANGO Stock Holding History

King Wealth Management Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-30,000
Closed -$460K – 161
2020
Q4 		$460K Sell
30,000
-5,000
-14% -$63.5K 0.11% 96
2020
Q3 		$422K Buy
+35,000
New +$332K 0.11% 97

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

King Wealth Management Group's ANGO Position: Q1 2021 in Review

King Wealth Management Group sold out of AngioDynamics (ANGO) in Q1 2021, closing a stake of 30,000 shares — an estimated $460K sold.

King Wealth Management Group first reported a position in ANGO in Q3 2020 and held it in 2 quarters. The position peaked at $460K in Q4 2020. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2021.

  • King Wealth Management Group reported no remaining AngioDynamics position as of Q1 2021 after selling out during the quarter.
  • King Wealth Management Group sold 30,000 AngioDynamics shares in Q1 2021, an estimated $460K.
  • King Wealth Management Group first reported a position in AngioDynamics in Q3 2020 and held it in 2 quarters.
  • King Wealth Management Group's AngioDynamics position peaked at $460K in Q4 2020.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2021.

Based on King Wealth Management Group's 13F filing for Q1 2021, filed 14 May 2021.